Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$8.06bn	128.73	n/a
MSBMesoblast	AU$1.91bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$901.48m	n/a	n/a
PYCPYC Therapeutics	AU$839.89m	n/a	n/a
IMMImmutep	AU$349.34m	n/a	n/a
DXBDimerix	AU$295.67m	n/a	n/a
CGSCogstate	AU$285.39m	25.76	n/a
RACRace Oncology	AU$204.11m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$161.61m	n/a	n/a
ATXAmplia Therapeutics	AU$135.78m	n/a	n/a
ALAArovella Therapeutics	AU$93.23m	n/a	n/a
BXNBioxyne	AU$88.12m	32.58	n/a
AGNArgenica Therapeutics	AU$85.18m	n/a	n/a
ATHAlterity Therapeutics	AU$79.81m	n/a	n/a
SNTSyntara	AU$78.96m	n/a	n/a
PEBPacific Edge	NZ$84.44m	n/a	n/a
ACWActinogen Medical	AU$75.19m	n/a	n/a
GD8GO-DX (Aust)	AU$61.94m	n/a	n/a
PIQProteomics International Laboratories	AU$61.57m	n/a	n/a
LTPLtr Pharma	AU$51.58m	n/a	n/a